PipelinePharma Logo
PipelinePharma Logo
Marketplace
Sign in Get started

daptomycin Injection, lyophilized 350 mg, 500 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP, Greece
Unavailable markets
Austria , Belgium , Bulgaria , Croatia , Cyprus , Czech Republic , Denmark , Estonia , Finland , France , Germany , Greece , Hungary , Iceland , Ireland , Italy , Kosovo , Latvia , Lithuania , Malta , Netherlands , Norway , Poland , Portugal , Romania , Slovakia , Spain , Sweden , United Kingdom , Vietnam
Available for
Distribution only
Comments
Product is not available for Europe
Manufacturer #298

This company is a global pharmaceutical and commercial organization that has been operating for over five decades. It specializes in injectable and prescription drug products, medical devices, and food supplements. Their manufacturing facilities are EU and US GMP approved. They have a strong presence in international markets, especially in Europe, North America, and Asia. The company also prides itself on its commitment to research and development of new products, particularly in the field of monoclonal antibodies. This commitment has earned them recognition and awards for their innovation and manufacturing excellence.

Manufacturer usually replies in 7 days

What is the drug Daptomycin?

Daptomycin is a lipopeptide antibiotic. It is used to treat bacterial infection of the skin caused by gram-positive microorganisms, Staphylococcus aureus, and bloodstream infection. It is administered only by intravenous processes. Daptomycin is a natural compound found in the saprotroph soil. Daptomycin was the first lipopeptide antimicrobial medication to be marketed. Today, it represents 83 % of in vitro antibiotics for gram-positive infections. Dasatinib medication is generally used to replace Gleevec when it is no longer efficient on patients or when the patients suffer from too strong side effects.

Wholesalers and manufacturers of Daptomycin

Daptomycin suppliers marketed it in the form of powder or injection for solutions. The medication is available either by its generic name, Daptomycin, first launched by Teva or by its brand name Cucibin marketed by Cubist Pharmaceuticals. Daptomycin was approved to be marketed in 2003 in the United States and in 2006 in the European Union.
The medication can be manufactured by Pfizer, Merck, and many others thanks to partnerships with Cubist. Counting only in China, there are more than 230 Daptomycin suppliers.

Daptomycin for sale:

The retail prices for one dose of Daptomycin intravenous powder for injection for 350 mg can fluctuate from $60 to $240, and for one dose of 500 mg, it can cost from $85 to $175, in the US market.
On Pipelinepharma online B2B marketplace, Daptomycin is mostly available from Turkey, where the medication was discovered. The platform helps Daptomycin distributors to find globally qualified manufacturers through quality control procedures. On the company website, you can find a list of many pharmaceutical products, including Daptomycin. If you are interested in this product, you can easily place an order on the Pipelinepharma platform to find Daptomycin manufacturers.

How to use Daptomycin drugs?

Depending on the Daptomycin treatment you follow, the use of the medication will be different. Taking Daptomycin for a skin and structure infection, an adult should take 4 mg/kg in vitro every 24 hours for 7 to 14 days.
If it is to treat Bacteremia, an adult should take 6 mg/kg IV every 24 hours for 2 to 6 weeks.
Daptomycin medication can have some side effects, the most common ones are: swelling of some body parts such as the face, arms, hands, lower legs, or feet, a fever, a rapid and unusual gain or loss of weight.
It must be stored in the refrigerator. If Daptomycin is mixed with a diluent, it still must be stored in the refrigerator but It must be taken within the following 48 hours.